Medical Science Liaison

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

J&J Innovative Medicine – MSL – Derm/Rheum

Location – Field Based – NW, Scotland & N. Ireland

Company background & culture:

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at https://www.jnj.com/. 

To be a scientific expert in the risks and benefits of relevant J&J Innovative Medicine (IM) therapeutics and their place in clinical practice and the therapy area, to ensure HCPs and other key stakeholders are well- placed to make evidence-based decisions in their practice, for the benefit of patients.

Taking lead responsibility for external engagement with a defined group of Leading Specialists involved in patient care and access to medicines within dermatology and rheumatology therapeutic area's (TA's).

• Uncovering insights that inform the company on clinical practice, HCP belief and understanding of data and HCP thought processes that guide their clinical practice.

• Where relevant and appropriate, discussing the risks, benefits, and place of J&J IM therapeutics and other data to facilitate evidence-based practice and maximisation of patient benefit. (e.g. responding to questions about J&J IM therapeutics from HCPs)

• Identify and delivery proactive engagement opportunities in line with compliance requirements of ABPI code to support the educational development of a broad community of HCPs within aligned TA. 

To work in the interests of patients, the healthcare system and J&J IM through quality scientific discussion and communication with Leading Specialists (LS) involved in the relevant therapy area; maintaining at least 80% of time externally focused and being seen as a credible and valuable partner in the delivery of care to patients.

Through activities in line with the Medical Affairs Plan, they contribute to short-term and long-term company goals. To take a proactive role in looking for strategically aligned opportunities to work with LS to optimise evidence generation, liaising with GCO, RWE as appropriate.

Key Role Activities

Therapy Area Knowledge

Maintain an up-to-date knowledge of the relevant J&J IM therapeutics, clinical practice, healthcare trends and other appropriate data / information within the TA.

• Build a good understanding of the healthcare environment including HTA process, effects on access to medications, competitive trends, and patient pathways.
• Identify emerging and evolving scientific concepts with future clinical implications.
• Through scientific interactions, gain insights into HCP opinions and beliefs, treatment patterns and scientific activities and share these with the MAF team and cross-functional colleagues.
• Partner with cross functional field-based roles to answer queries, address appropriately aligned HCPs unmet needs and share insights.

Customer Excellence

• Use available platforms and tools to develop and maintain a contact network of LS that meet criteria for MSL engagement
• Understand and leverage a map of influence within the external stakeholder community to ensure that the right amount and level of information is available to them and enables appropriate decision making.
• Lead at congress participation e.g., attend medical stand and write assigned summary reports at congress and relay to Head Office for internal regional knowledge sharing.
• Understand LS needs, key value drivers, practical treatment patterns and scientific activities within the therapeutic area.
• Develop and execute LS Engagement Plans in close collaboration and coordination with other functions.
• When appropriate, communicate the patient value of company medicines and services to LS and other HCPs based on evidence and science.
• Where appropriate and / or requested, contribute to market access activities e. g., through clinical evidence presentation.
• Represent the company to other TA stakeholders including professional associations and patient organisations as required.
• Identify, support and brief speakers for medical education.
• Where appropriate, communicate non-promotional information about J&J IM, including pipeline, research and development programs and other relevant information.
• Participate in Advisory Boards in cooperation with the MAF team.
• Identify ways in which technology can improve effectiveness of MSLs and use digital technologies and new media to support/enhance MSL interactions.

Evidence Generation

• Contribute to evidence generation strategy, planning, design, and execution in line with the overall MSL strategy and plan, and in support of individual LS engagement plans as required.
• Support the set up and follow up of registries and other non-interventional Medical Affairs studies.
• Understand RWE methodologies, identify data needs and opportunities, support protocol development and engage in discussions with LS to help design RWE projects.
• Support GCO with trial site strategy, identification, and management.
• Support LS proposals for IISs and ensure they are discussed, decisions are taken, and appropriate processes are followed.
• Support post marketing surveillance and expanded access programs.
• Support, through LS networks, the identification of research with respect to potential New Molecular Entities.

Internal Collaboration

• Develop and maintain strong working relationships with MAF TA colleagues and relevant cross-functional field team colleagues.
• Contribute to the development of a cohesive MSL TA team and a cross-TA network of MSLs.
• Contribute to activities in support of MSL Excellence such as the MSL Forum and EMEA led MSL development programs.

Essential Knowledge and Skills

• Knowledge of NHS priorities in TA

• Knowledge of the current and emerging science in TA
• Market Access process for the TA and geography